Top broker Goldman Sachs reckons US big pharma stock Eli Lilly And Co (NYSE: LLY) has the credentials to replace electric vehicle producer Tesla Inc (NASDAQ: TSLA) in the Magnificent Seven.
That’s a pretty big call, but then again, Eli Lilly’s GLP-1 diabetes and obesity drugs are a pretty big deal.
Why could this US stock replace Tesla in the Magnificent Seven?
Just as electric vehicles have been a game changer in car manufacturing, GLP-1 drugs are a game changer in…
Comments are closed